Editorial comment on: FGFR3 mutations indicate better survival in invasive upper urinary tract and bladder tumours.
Malats
Núria
N
Real
Francisco X
FX
D002295:Carcinoma, Transitional Cell / Q000235:genetics* / Q000401:mortality / Q000473:pathology; D006801:Humans; D007680:Kidney Neoplasms / Q000235:genetics* / Q000401:mortality / Q000473:pathology; D009154:Mutation; D009361:Neoplasm Invasiveness; D011379:Prognosis; D051498:Receptor, Fibroblast Growth Factor, Type 3 / Q000235:genetics*; D015996:Survival Rate; D014516:Ureteral Neoplasms / Q000235:genetics* / Q000401:mortality / Q000473:pathology; D001749:Urinary Bladder Neoplasms / Q000235:genetics* / Q000401:mortality / Q000473:pathology
C496365:FGFR3 protein, human; D051498:Receptor, Fibroblast Growth Factor, Type 3